Previous Article | Next Article ![]()
Infect Immun, August 1998, p. 3705-3710, Vol. 66, No. 8
Departments of Virus and Cell
Biology1 and
Clinical
Research,2 Merck Research Laboratories, West
Point, Pennsylvania
Received 13 February 1998/Returned for modification 14 April
1998/Accepted 1 May 1998
Streptococcus pneumoniae is responsible for high rates
of pneumococcal bacteremia, meningitis, pneumonia, and acute otitis media worldwide. Protection from disease is conferred by antibodies specific for the polysaccharide (Ps) capsule of the bacteria. Of the
four types of group 9 pneumococci, types 9N and 9V cause the most
disease, and both types are included in the polyvalent pneumococcal
vaccine. The type 9V capsule consists of repeating pentasaccharide
units linearly arranged, with an average of 1 to 2 mol of O-acetate
side chains per mol of repeat units, added in a complex pattern in
which not all repeat units are alike.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Antibody Responses to Capsular Polysaccharide
Backbone and O-Acetate Side Groups of Streptococcus
pneumoniae Type 9V in Humans and Rhesus Macaques
-GlcA residues may be
O-acetylated in the 2 (17%) or 3 (25%) position and
-ManNAc
residues may be O-acetylated in the 4 (6%) or 6 (55%) position. Under
certain conditions, the O-acetate side chains are subject to oxidation,
which results in subsequent de-O-acetylation of a significant number of
the repeat units. This de-O-acetylation could adversely affect the
efficacy of a vaccine containing the 9V Ps. A study was undertaken to
compare the relative contributions of O-acetate and Ps backbone
epitopes in the immune response to S. pneumoniae 9V
type-specific Ps. In both an infant rhesus monkey model and
humans, antibodies against the non-O-acetylated 9V backbone as well as
against O-acetylated 9V Ps were detected. Functional (opsonophagocytic)
activity was observed in antisera in which the predominant species of
antibody recognized de-O-acetylated 9V Ps. We concluded that the
O-acetate side groups, while recognized, are not essential to the
ability of the 9V Ps to induce functional antibody responses.
*
Corresponding author. Mailing address: Merck Research
Laboratories, P.O. Box 4, WP26-253, West Point, PA 19486. Phone: (215) 652-3683. Fax: (215) 652-8127. E-mail:
john_donnelly{at}merck.com.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»